Paper40140720
Optimization of adeno-associated viral (AAV) gene therapies vectors for balancing efficacy, longevity and safety for clinical application.
Mehta N and 16 others. Gene Ther, 2025. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Optimization of adeno-associated viral (AAV) gene therapies vectors for balancing efficacy, longevity and safety for clinical application. Papers, record 40140720. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40140720
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Optimization of adeno-associated viral (AAV) gene therapies vectors for balancing efficacy, longevity and safety for clinical application.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dependovirus | Major topic |
| Genetic Therapy | Major topic |
| Genetic Vectors | Major topic |
| Hyperlipoproteinemia Type I | Major topic |
| Animals | |
| Mice | |
| Humans | |
| CpG Islands | |
| Disease Models, Animal | |
| Lipoprotein Lipase |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CGT-101 | Gouvernement du Canada | National Research Council Canada (Conseil national de recherches Canada) | PubMed | ||
| 201910MFE-430323-FPP-CAAA-267763 | Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) | PubMed | ||
| RT-2020-0381 | Michael Smith Foundation for Health Research (MSFHR) | PubMed |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35283274 | Durability of transgene expression after rAAV gene therapy. | Mol Ther | 2022 | https://conductscience.org/library/papers/35283274 | PubMed |
| 2 | 38528615 | Current and emerging gene therapies for haemophilia A and B. | Haemophilia | 2024 | https://conductscience.org/library/papers/38528615 | PubMed |
| 3 | 27412455 | Long-Term Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and Its Effect on Lipoprotein Lipase Deficiency-Induced Pancreatitis. | Hum Gene Ther | 2016 | https://conductscience.org/library/papers/27412455 | PubMed |
| 4 | 15353045 | Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation. | Hum Gene Ther | 2004 | https://conductscience.org/library/papers/15353045 | PubMed |
| 5 | 32710825 | Quantification of CpG Motifs in rAAV Genomes: Avoiding the Toll. | Mol Ther | 2020 | https://conductscience.org/library/papers/32710825 | PubMed |
| 6 | 18802015 | Intramuscular administration of AAV1-lipoprotein lipase S447X lowers triglycerides in lipoprotein lipase-deficient patients. | Arterioscler Thromb Vasc Biol | 2008 | https://conductscience.org/library/papers/18802015 | PubMed |
| 7 | 10467369 | The effect of CpG sequences on the B cell response to a viral glycoprotein encoded by a plasmid vector. | Gene Ther | 1999 | https://conductscience.org/library/papers/10467369 | PubMed |
| 8 | 34135899 | Effect of CpG Depletion of Vector Genome on CD8+ T Cell Responses in AAV Gene Therapy. | Front Immunol | 2021 | https://conductscience.org/library/papers/34135899 | PubMed |
| 9 | 16716106 | Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutation. | Hum Gene Ther | 2006 | https://conductscience.org/library/papers/16716106 | PubMed |
| 10 | 22717743 | Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial. | Gene Ther | 2013 | https://conductscience.org/library/papers/22717743 | PubMed |
| 11 | 16574898 | Lipoprotein lipase S447X: a naturally occurring gain-of-function mutation. | Arterioscler Thromb Vasc Biol | 2006 | https://conductscience.org/library/papers/16574898 | PubMed |
| 12 | 31839483 | The Effect of CpG Sequences on Capsid-Specific CD8+ T Cell Responses to AAV Vector Gene Transfer. | Mol Ther | 2020 | https://conductscience.org/library/papers/31839483 | PubMed |
| 13 | 8732771 | Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. | J Lipid Res | 1996 | https://conductscience.org/library/papers/8732771 | PubMed |
| 14 | 17369837 | CD8(+) T-cell responses to adeno-associated virus capsid in humans. | Nat Med | 2007 | https://conductscience.org/library/papers/17369837 | PubMed |
| 15 | 12454259 | Lipoprotein lipase: genetics, lipid uptake, and regulation. | J Lipid Res | 2002 | https://conductscience.org/library/papers/12454259 | PubMed |
| 16 | 27188756 | A simple solution for antibody signal enhancement in immunofluorescence and triple immunogold assays. | Histochem Cell Biol | 2016 | https://conductscience.org/library/papers/27188756 | PubMed |
| 17 | 1557997 | Chylomicronemia syndrome. | Adv Intern Med | 1992 | https://conductscience.org/library/papers/1557997 | PubMed |
| 18 | 34084173 | Challenges Posed by Immune Responses to AAV Vectors: Addressing Root Causes. | Front Immunol | 2021 | https://conductscience.org/library/papers/34084173 | PubMed |
| 19 | 28325286 | Inclusion of the Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances AAV2-Driven Transduction of Mouse and Human Retina. | Mol Ther Nucleic Acids | 2017 | https://conductscience.org/library/papers/28325286 | PubMed |
| 20 | 32332431 | Regulation of lipoprotein lipase-mediated lipolysis of triglycerides. | Curr Opin Lipidol | 2020 | https://conductscience.org/library/papers/32332431 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42353791 | Building CRISPR-Based Gene-Editing Platforms for Personalized Medicine: The Next Step in Interventional Genetics. | Genes (Basel) | 2026 | https://conductscience.org/library/papers/42353791 | PubMed |
| 42137590 | Adeno-associated virus-induced neurotoxicity is prevented by CpG depletion. | Mol Ther Adv | 2026 | https://conductscience.org/library/papers/42137590 | PubMed |
| 41914423 | [Adeno-associated virus-mediated gene therapy for genetic epilepsy: prospects and challenges]. | Zhongguo Dang Dai Er Ke Za Zhi | 2026 | https://conductscience.org/library/papers/41914423 | PubMed |
| 41910720 | Strategies for Evading Cellular Immunity Against Recombinant AAV Vectors in Gene Therapy. | Curr Med Sci | 2026 | https://conductscience.org/library/papers/41910720 | PubMed |
| 41322190 | Mechanistic and functional characterization of ABTB2 as a novel target for pancreatic cancer therapy. | Mol Ther Oncol | 2025 | https://conductscience.org/library/papers/41322190 | PubMed |
| 41304828 | Emerging Technologies Tackling Adeno-Associated Viruses (AAV) Immunogenicity in Gene Therapy Applications. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41304828 | PubMed |
| 40799205 | Development of VNX-101, an adeno-associated virus with less immunogenicity and efficient long-term expression of a CD19 T cell engager. | Mol Ther Methods Clin Dev | 2025 | https://conductscience.org/library/papers/40799205 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TLR9 | 54106 | PubTator's text mining | https://conductscience.org/library/genes/54106 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40140720
GET https://conductscience.org/api/papers/v1/40140720/references?page=2